Why Is Cognex (CGNX) Down 16.9% Since Last Earnings Report?

Core Viewpoint - Cognex Corporation has shown a mixed performance in its recent earnings report, with a notable earnings beat and revenue growth, but shares have underperformed the S&P 500 by approximately 16.9% since the last report, raising questions about future performance leading up to the next earnings release [1]. Financial Performance - Cognex reported Q4 2025 non-GAAP earnings of 27 cents per share, exceeding the Zacks Consensus Estimate by 23.85%, and reflecting a 35% year-over-year increase in EPS [2]. - Revenues reached $252.3 million, surpassing the Zacks Consensus Estimate by 7.17%, and showed a 10% year-over-year growth on a reported basis and 9% on a constant-currency basis [3]. - The gross margin on a non-GAAP basis was 71.6%, expanding by 220 basis points year over year, while the adjusted EBITDA margin rose 420 basis points to 22.7%, marking the sixth consecutive quarter of year-over-year expansion [5]. Regional Performance - On a constant-currency basis, revenue growth by region in Q4 2025 included over 11% in the Americas, over 13% in Europe driven by packaging strength, and more than 7% in Greater China due to consumer electronics and semiconductor growth, while Other Asia remained flat year-over-year [4]. Operating Expenses - Selling, general & administrative (SG&A) expenses increased by 0.1% year over year to $94.6 million, while research & development (R&D) expenses rose by 10.8% to $36.1 million. SG&A expenses as a percentage of revenues decreased by 360 basis points to 37.5% [6]. Cash Flow and Shareholder Returns - Cognex generated $74.9 million in cash from operating activities in Q4 2025, with a free cash flow of $72.3 million, reflecting a 47% year-over-year increase [8][10]. - In Q4 2025, the company repurchased $25 million in shares and paid $14 million in dividends, with a total of $151 million in share buybacks and $55 million in dividends for the year [9]. Future Guidance - For Q1 2026, Cognex anticipates non-GAAP revenues between $235 million and $255 million, with an adjusted EBITDA margin of 19-22% and non-GAAP EPS expected between 22 cents and 26 cents [11]. - The company is executing a portfolio optimization strategy, exiting approximately $22 million of low-growth revenues, and has identified $35-$40 million in net operating expense reductions for 2026 [12]. Long-term Outlook - Cognex's long-term outlook includes a mid to high-single-digit organic revenue growth expectation for 2026, with specific growth projections across various verticals [13]. - The company updated its multi-year framework, raising the through-cycle adjusted EBITDA margin range to 25-31% and maintaining a revenue CAGR of 13-14%, with a target of at least 20% adjusted EPS growth by the end of 2026 [14]. Market Sentiment - There has been an upward trend in estimates revisions, with the consensus estimate shifting by 23.75% recently, indicating positive market sentiment [15]. - Cognex currently holds a Zacks Rank of 1 (Strong Buy), suggesting expectations for above-average returns in the coming months [17].